Literature DB >> 22196955

Mutation analysis of VCP in familial and sporadic amyotrophic lateral sclerosis.

Kelly L Williams1, Jennifer A Solski, Garth A Nicholson, Ian P Blair.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by the progressive loss of motor neurons in the motor cortex, brain stem and spinal cord. Mutations in the valosin-containing protein gene (VCP) were recently described in ALS families. Some of these families included diagnoses of other clinical features including frontotemporal dementia, Paget's disease, inclusion body myopathy, Parkinsonism and limb weakness. We sought to determine the prevalence of VCP mutations in Australian familial (n = 131) and sporadic (n = 48) ALS cohorts diagnosed with classic ALS. No mutations were identified indicating that VCP mutations are not a common cause of classic ALS among Australian cases with predominantly European ancestry.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22196955     DOI: 10.1016/j.neurobiolaging.2011.11.022

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  9 in total

Review 1.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

2.  A progressive translational mouse model of human valosin-containing protein disease: the VCP(R155H/+) mouse.

Authors:  Angèle Nalbandian; Katrina J Llewellyn; Mallikarjun Badadani; Hong Z Yin; Christopher Nguyen; Veeral Katheria; Giles Watts; Jogeshwar Mukherjee; Jouni Vesa; Vincent Caiozzo; Tahseen Mozaffar; John H Weiss; Virginia E Kimonis
Journal:  Muscle Nerve       Date:  2012-11-21       Impact factor: 3.217

Review 3.  Regulation of molecular chaperones through post-translational modifications: decrypting the chaperone code.

Authors:  Philippe Cloutier; Benoit Coulombe
Journal:  Biochim Biophys Acta       Date:  2013-02-28

Review 4.  Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis.

Authors:  Emanuele D'Amico; Pam Factor-Litvak; Regina M Santella; Hiroshi Mitsumoto
Journal:  Free Radic Biol Med       Date:  2013-06-21       Impact factor: 7.376

Review 5.  Frontotemporal dementia: a bridge between dementia and neuromuscular disease.

Authors:  Adeline S L Ng; Rosa Rademakers; Bruce L Miller
Journal:  Ann N Y Acad Sci       Date:  2014-12-30       Impact factor: 5.691

6.  Myogenic differentiation of VCP disease-induced pluripotent stem cells: A novel platform for drug discovery.

Authors:  Katrina J Llewellyn; Angèle Nalbandian; Lan N Weiss; Isabela Chang; Howard Yu; Bibo Khatib; Baichang Tan; Vanessa Scarfone; Virginia E Kimonis
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

7.  Phenotype of VCP Mutations in Chinese Amyotrophic Lateral Sclerosis Patients.

Authors:  Shu-Yan Feng; Han Lin; Chun-Hui Che; Hua-Pin Huang; Chang-Yun Liu; Zhang-Yu Zou
Journal:  Front Neurol       Date:  2022-02-07       Impact factor: 4.003

Review 8.  The genetics of amyotrophic lateral sclerosis: current insights.

Authors:  Afnan A Alsultan; Rachel Waller; Paul R Heath; Janine Kirby
Journal:  Degener Neurol Neuromuscul Dis       Date:  2016-05-13

9.  VRK1 functional insufficiency due to alterations in protein stability or kinase activity of human VRK1 pathogenic variants implicated in neuromotor syndromes.

Authors:  Elena Martín-Doncel; Ana M Rojas; Lara Cantarero; Pedro A Lazo
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.